题名

Hydroalcoholic extract of Passiflora incarnata improves the autistic-like behavior and neuronal damage in a valproic acid-induced rat model of autism

DOI

10.1016/j.jtcme.2023.02.005

作者

Fatemeh Amini;Hossein Amini-Khoei;Sara Haratizadeh;Mohammad Setayesh;Mohsen Basiri;Mahboobeh Raeiszadeh;Masoumeh Nozari

关键词

Passiflora ; Extract ; Autism ; Oxidative stress ; Behavior ; Valproic acid

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

13卷4期(2023 / 07 / 01)

页次

315 - 324

内容语文

英文

中文摘要

Experimental autism in rodents can be caused by prenatal valproic acid (VPA) exposure. Some diseases, such as attention-deficit hyperactivity disorder (ADHD), insomnia, opiate withdrawal, and generalized anxiety disorder can be treated by consuming Passiflora incarnata, due to the possession of bioactive compounds like alkaloids, phenols, and flavonoids. The present study aims to investigate the role of the hydroalcoholic extract of Passiflora incarnata in behavioral and oxidative stress aberrations induced by VPA. On the gestational day (GD), 12.5, pregnant Wistar rats received VPA (600 mg/kg subcutaneously). Male pups were treated with the extract (30,100, and 300 mg/kg) from postnatal day 35 to the end of the experiment, and underwent behavioral testing to evaluate locomotion, repetitive, and stereotyped movements, anxiety, and social and cognitive behaviors. After behavioral testing, the blood sample was taken from the left ventricle to determine serum catalase (CAT), superoxide dismutase (SOD), malon-dialdehyde (MDA), and total antioxidant capacity (TAC). Then the animals were euthanized and their brains were taken out for histological assays of the prefrontal cortex (PFC) and CA1 hippocampus with hematoxylin/eosin. The total phenol and flavonoid content and antioxidant activity of the extract were also measured. A significant improvement was observed in behavioral disturbances, particularly with 300 mg/kg of Passiflora. Moreover, the formation of oxidative stress markers significantly decreased at this dose. The extract also reduced the percentage of damaged cells in the CA1 and PFC. The results indicated that Passiflora extract could ameliorate VPA-induced behavioral aberrations possibly due to the antioxidant actions of its bioactive compounds.

主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Ebrahimpour, N,Khazaneha, M,Mehrbani, M,Rayegan, P,Raeiszadeh, M(2021).Efficacy of Herbal Based Syrup on male sexual experiences: a double-blind randomized clinical trial.J. Tradit. Complement. Med.,11,103-108.
    連結:
  2. Avelino da Silva, J,De Carvalho da Costa, MJ,Rodrigues da Alves M da, C,Fernandes da Braga, JE,Bezerra Luna da Lima, CM,De Morais da Pordeus, LC(2017).Effects of the single supplementation and multiple doses of Passiflora incarnata L. on human anxiety: a Clinical Trial, Double-blind, Placebo-controlled, Randomized.Int Arch Med,10
  3. Benzie, IFF,Strain, JJ.(1996).The ferric reducing ability of plasma (FRAP) as a measure of‘"Antioxidant power"’: the FRAP assay Iris.Anal Methods,7,70-76.
  4. Bhatt, ID,Rawat, S,Rawal, RS.(2011).Antioxidants in medicinal plants.
  5. Bjørklund, G,Meguid, NA,El-bana, MA(2020).Oxidative stress in autism spectrum disorder.Mol Neurobiol,57,2314-2332.
  6. Buege, JA,Aust, SD(1978).Biomembranes - Part C: biological oxidations.Methods Enzymol,52,302-310.
  7. Cai, Y,Luo, Q,Sun, M,Corke, H(2004).Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer.Life Sci,74
  8. Cardiff, RD,Miller, CH,Munn, RJ(2014).Manual hematoxylin and eosin staining of mouse tissue sections.Cold Spring Harb Protoc,655-658.
  9. Crawley, JN.(2007).Mouse behavioral assays relevant to the symptoms of autism.Brain Pathol,448-459.
  10. Damodaran, LPM,Arumugam, G(2011).Urinary oxidative stress markers in children with autism.Redox Rep,16,216-222.
  11. Elrod, MG,Nylund, CM,Susi, AL(2016).Prevalence of diagnosed sleep disorders and related diagnostic and surgical procedures in children with autism spectrum disorders.J Dev Behav Pediatr,37,377-384.
  12. Faatehi, M,Basiri, M,Nezhadi, A(2019).Early enriched environment prevents cognitive impairment in an animal model of schizophrenia induced by MK-801: role of hippocampal BDNF.Brain Res,1711,115-119.
  13. Fedoce A, das G,Ferreira, F(2018).The role of oxidative stress in anxiety disorder: cause or consequence?.Free Radic Res
  14. Fonseca, LRd,Rodrigues R de, A,Ramos A de, S(2020).Herbal medicinal products from passiflora for anxiety: an unexploited potential.Sci World J
  15. Gandhi, T,Lee, CC(2021).Neural mechanisms underlying repetitive behaviors in rodent models of autism spectrum disorders.Front Cell Neurosci,14,1-44.
  16. Ghotbi Ravandi, S,Shabani, M,Bashiri, H,Saeedi Goraghani, M,Khodamoradi, M,Nozari, M(2019).Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia.Neurosci Lett,706,151-157.
  17. Grabrucker, AM(2013).Environmental factors in autism.Front Psychiatr,3,1-13.
  18. Haratizadeh, S,Parvan, M,Mohammadi, S,Shabani, M,Nozari, M(2021).An overview of modeling and behavioral assessment of autism in the rodent.Int J Dev Neurosci.,81,221-228.
  19. Haratizadeh, S,Ranjbar, M,Darvishzadeh-Mahani, F,Basiri, M,Nozari, M(2023).The effects of postnatal erythropoietin and nano-erythropoietin on behavioral al-terations by mediating K-Cl co-transporter 2 in the valproic acid-induced rat model of autism.Dev Psychobiol,65,e22353.
  20. Ingale, SP,Kasture, SB(2017).Protective effect of standardized extract of passiflora incarnata flower in Parkinson's and alzheimer's disease.Ancient Sci Life,36,200.
  21. Ingale, SP,Kasture, SB(2012).International journal of phytopharmacology psycho-pharmacological profile of passiflora incarnata linn in mice.Int J Phytopharm,3,263.
  22. Janda, K,Wojtkowska, K,Jakubczyk, K,Antoniewicz, J,Zydecka, KS(2020).Passiflora incarnata in Neuropsychiatric Disorders-A Systematic Review.Nutrients,12(12)
  23. Jawna-Zboińska, K,Blecharz-Klin, K,Joniec-Maciejak, I(2016).Passiflora incarnate L. Improves spatial memory, reduces stress, and affects neurotransmission in rats.Phyther. Res,30,781-789.
  24. Kim, GH,Kim, Y,Yoon, S,Kim, SJ,Yi, SS(2020).Sleep-inducing effect of Passiflora incarnata L. extract by single and repeated oral administration in rodent animals.Food Sci Nutr,8,557-566.
  25. Kim, GH,Lim, K,Yang, HS(2019).Improvement in neurogenesis and memory function by administration of Passiflora incarnata L. extract applied to sleep disorder in rodent models.J Chem Neuroanat,98,27-40.
  26. Kim, KC,Lee, DK,Go, HS(2014).Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring.Mol Neurobiol,49,512-528.
  27. Kim, M,Lim, H-S,Lee, H-H,Kim, T-H(2017).Role identification of passiflora incarnate linnaeus : a mini review.J. Menopausal Med,23,156.
  28. Li, K,Li, L,Cui, B(2018).Early postnatal exposure to airborne fine particulate matter induces autism-like phenotypes in male rats.Toxicol Sci.,162,189-199.
  29. Liu, Z,Tao, X,Zhang, C,Lu, Y,Wei, D(2005).Protective effects of hyperoside (quercetin3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide.Biomed Pharmacother,59,481-490.
  30. Mabunga, DFN,Gonzales, ELT,Kim, J,Kim, KC,Shin, CY(2015).Exploring the validity of valproic acid animal model of autism.Exp. Neurobiol.,24,285-300.
  31. Masteikova, R,Bernatoniene, J,Bernatoniene, R,Velziene, S.(2008).Antiradical activities of the extract of Passiflora incarnata.Acta Pol. Pharm.-Drug Res,65,577-583.
  32. Michael, HSR,Mohammed, NB,Ponnusamy, S,Edward Gnanaraj, W(2022).A folk medicine: passiflora incarnata L. Phytochemical profile with antioxidant potency.Turkish J. Pharm. Sci,19
  33. Mohammadi, S,Asadi-Shekaari, M,Basiri, M,Parvan, M,Shabani, M,Nozari, M(2020).Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.Psycho-pharmacology,237,199-208.
  34. Naghavi, HR,Vazirian, M,Shayeganpour, A,Rashidi, H,Khani, M,Akhondzadeh, S(2001).Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.J Clin Pharm Therapeut,26,363-367.
  35. Ozarowski, M,Karpiński, TM(2020).Extracts and flavonoids of passiflora species as promising anti-inflammatory and antioxidant substances.Curr Pharmaceut Des,27,2582-2604.
  36. Pasciuto, E,Borrie, SCC,Kanellopoulos, AKK(2015).Autism Spectrum Disorders: translating human deficits into mouse behavior.Neurobiol Learn Mem,124,71-87.
  37. Raeiszadeh, M,Pardakhty, A,Sharififar, F,Mehrabani, Mehrnaz,Nejatmehrab-Kermani, H,Mehrabani, Mitra(2018).Phytoniosome: a novel drug delivery for myrtle extract.Iran. J Pharm Res,17,804-817.
  38. Rameshk, M,Sharififar, F,Farsinejad, A(2018).In vitro proliferation and wound healing effects of Narcissus tazetta L. bulb on primary human dermal fibro-blasts.Journal of Pharmaceutical Research International,20,1-13.
  39. Rodgers, RJ,Dalvi, A(1997).Anxiety, defence and the elevated plus-maze.Neurosci Biobehav Rev,801-810.
  40. Schneider, T,Przewłocki, R,Tomasz Schneider, RP(2005).Behavioral al-terations in rats prenatally to valproic acid: animal model of autism.Neuro-psychopharmacology,30,80-89.
  41. Singh, B,Singh, D,Goel, RK(2012).Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression.J Ethnopharmacol,139,273-279.
  42. Sinha, AK(1972).Colorimetric assay of catalase.Anal Biochem,47,389-394.
  43. Taylor, MJ,Rosenqvist, MA,Larsson, H(2021).Etiology of Autism Spectrum Disorders and Autistic Traits Over Time.JAMA Psychiatry,77,936-943.
  44. Trial, AAC,Rodrigues, C(2017).Effects of the single supplementation and multiple doses of Passiflora incarnata L. on human anxiety: A Clinical Trial, Double-blind, Placebo-controlled, Randomized.International Archives of Medicine,10,1-9.
  45. Wang, Y,Zhao, S,Liu, X,Zheng, Y,Li, L,Meng, S(2018).Biomedicine & Pharmacotherapy Oxytocin improves animal behaviors and ameliorates oxidative stress and in flammation in autistic mice.Biomed Pharmacother,107,262-269.
  46. Xu, Y,Wang, C,Klabnik, J,O’Donnell, J(2014).Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment.Curr Neuropharmacol,12,108-119.
  47. Zhang, Y,Cui, W,Zhai, Q,Zhang, T,Wen, X(2017).N-acetylcysteine ameliorates epetitive/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism.Mol Med Rep,16,2233-2240.
  48. Zhang, Y,Yang, C,Yuan, G,Wang, Z,Cui, W,Li, R(2015).Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive/stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid.Int J Mol Med,35,263-270.